Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
0.6930
-0.0484 (-6.53%)
At close: Apr 21, 2026, 4:00 PM EDT
0.7069
+0.0139 (2.01%)
After-hours: Apr 21, 2026, 4:24 PM EDT
Tenaya Therapeutics Market Cap
Tenaya Therapeutics has a market cap or net worth of $150.38 million as of April 21, 2026. Its market cap has increased by 79.02% in one year.
Market Cap
150.38M
Enterprise Value
62.85M
1-Year Change
79.02%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since July 30, 2021, Tenaya Therapeutics's market cap has decreased from $603.63M to $150.38M, a decrease of -75.09%. That is a compound annual growth rate of -25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 160.88M | 4.44% |
| Dec 31, 2025 | 154.04M | 35.98% |
| Dec 31, 2024 | 113.29M | -48.67% |
| Dec 29, 2023 | 220.68M | 71.58% |
| Dec 30, 2022 | 128.62M | -83.56% |
| Dec 31, 2021 | 782.28M | 29.59% |
| Jul 30, 2021 | 603.63M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 179.18M |
| Unicycive Therapeutics | 177.17M |
| Black Diamond Therapeutics | 175.30M |
| Fate Therapeutics | 161.61M |
| Galectin Therapeutics | 161.28M |
| Biomea Fusion | 159.78M |
| Spero Therapeutics | 159.20M |
| Connect Biopharma Holdings | 158.82M |